BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9292064)

  • 1. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis.
    Dummer W; Bröcker EB; Bastian BC
    Br J Dermatol; 1997 Aug; 137(2):185-7. PubMed ID: 9292064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis.
    Dummer W; Rose C; Bröcker EB
    Arch Dermatol Res; 1998 Nov; 290(11):598-602. PubMed ID: 9860279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo relevance of CD30 in atopic dermatitis.
    Caproni M; Bianchi B; D'Elios MM; De Carli M; Amedei A; Fabbri P
    Allergy; 1997 Nov; 52(11):1063-70. PubMed ID: 9404557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).
    Bengtsson A; Holm L; Bäck O; Fransson J; Scheynius A
    Clin Exp Immunol; 1997 Sep; 109(3):533-7. PubMed ID: 9328133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble cytokine receptor CD30 in atopic disorders: a case-control study.
    Latza U; Davis S; Wilhelm D; McKnight B; Seyfarth M; Stein H
    Clin Exp Allergy; 1999 Jan; 29(1):97-104. PubMed ID: 10051708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis.
    Fölster-Holst R; Henseler T; Wehde J; Lemke H; Weichenthal M; Christophers E; Hansen HP
    Acta Derm Venereol; 2002; 82(4):245-8. PubMed ID: 12361126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM; El-Hadidi ES
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD30 in pediatric patients with atopic dermatitis.
    Frezzolini A; Paradisi M; Ruffelli M; Cadoni S; De Pità O
    Allergy; 1997 Jan; 52(1):106-9. PubMed ID: 9062638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26.
    Katoh N; Hirano S; Suehiro M; Ikenaga K; Yamashita T; Sugawara N; Yasuno H
    Clin Exp Immunol; 2000 Aug; 121(2):187-92. PubMed ID: 10931130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention.
    Bottari V; Frezzolini A; Ruffelli M; Puddu P; Fontana L; De Pità O
    Allergy; 1999 May; 54(5):507-10. PubMed ID: 10380784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD30 and CD23 in cord blood are not related to atopy in early childhood.
    Oymar K; Laerdal A; Bjerknes R
    Pediatr Allergy Immunol; 2000 Nov; 11(4):220-4. PubMed ID: 11110575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen-induced CD30 expression on T cells of atopic asthmatics.
    Leonard C; Tormey V; Faul J; Burke CM; Poulter LW
    Clin Exp Allergy; 1997 Jul; 27(7):780-6. PubMed ID: 9249270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous CD30+ cells in children with atopic dermatitis.
    Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R
    Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD30 and cyclosporine in severe atopic dermatitis.
    Caproni M; Salvatore E; Cardinali C; Brazzini B; Fabbri P
    Int Arch Allergy Immunol; 2000 Apr; 121(4):324-8. PubMed ID: 10828723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
    Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
    Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity.
    Frezzolini A; Paradisi M; Zaffiro A; Provini A; Cadoni S; Ruffelli M; De Pità O
    Allergy; 2002 Sep; 57(9):815-20. PubMed ID: 12169178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy.
    Holmlund U; Bengtsson A; Nilsson C; Kusoffsky E; Lilja G; Scheynius A; Sverremark-Ekström E
    Clin Exp Allergy; 2003 Nov; 33(11):1531-6. PubMed ID: 14616865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating skin-homing T cells in atopic dermatitis. Selective up-regulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy.
    Piletta PA; Wirth S; Hommel L; Saurat JH; Hauser C
    Arch Dermatol; 1996 Oct; 132(10):1171-6. PubMed ID: 8859027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.
    Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML
    Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis.
    Yamamoto J; Adachi Y; Onoue Y; Kanegane H; Miyawaki T; Toyoda M; Seki T; Morohashi M
    Allergy; 2000 Nov; 55(11):1011-8. PubMed ID: 11097309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.